Skip to content
by Legal Desire
City

Seattle

33 announced deals involving Seattle, most recent first, with the firms that advised on each.

Most recent

SEARCH ALL 33
DLA Piper advises underwriters in Strive’s US$630 million preferred stock initial public offering 28 Oct 2026
Capital Markets & IPO Financial Services DLA Piper USD 630m 9 NAMED
DLA Piper advises Delta-v Capital in Series B investment advancing enterprise AI security 7 Sept 2026
Venture Capital & Growth Technology DLA Piper USD 100m 4 NAMED
Latham & Watkins Advises the Estate of Paul G. Allen in Completed Sale of Seattle Seahawks 7 Sept 2026
M&A Other Latham & Watkins LLP 14 NAMED
Latham & Watkins Advises the Estate of Paul G. Allen in Agreement to Sell Seattle Seahawks 14 Jul 2026
M&A Other Latham & Watkins LLP 13 NAMED
DLA Piper advises Elroy Air on US$1 billion business combination and planned Nasdaq listing 30 Jun 2026
Capital Markets & IPO DLA Piper USD 1bn 9 NAMED
DLA Piper advises Cantor Equity Partners III, Inc. in closing of US$1.7 billion business combination with AIR Limited 5 Jun 2026
M&A DLA Piper USD 1.70bn 18 NAMED
DLA Piper advises Rare Earths Americas on US$69 million upsized initial public offering 5 Jun 2026
Capital Markets & IPO Mining & Metals DLA Piper USD 69m 8 NAMED
DLA Piper advises Fixated on acquisition of Studio71 5 Jun 2026
M&A Technology DLA Piper 9 NAMED
DLA Piper advised Cantor Equity Partners III, Inc., a special purpose acquisition company sponsored by an affiliate of Cantor Fitzgerald, in its entry into a business combination agreement with AIR Limited, a global provider of hookah and advanced inhalation technologies. Upon closing, the transaction will result in the combined company, AIR Global Limited, becoming publicly listed in the United States with an enterprise value of US$1.749 billion. The DLA Piper team included Partners Stephen Alicanti and Sidney Burke (both New York), and Associates Carina Meleca (New York), Nick Young (Phoenix), and Luke Postma (Seattle). Additional support was provided by DLA Piper Partners William Bartow, Jae Kim (both Philadelphia), Paolo Morante (New York), Julia Kovacs, Aurelie Ercoli (both Washington, DC), Victoria Richter (Chicago), and Sarah Tauman (San Francisco); Of Counsels Arlette Grabczynska (Chicago), Michael Madigan (New York), and Priya Narahari (Philadelphia); Senior Attorney Brittany Ellenberg (San Francisco); and Associates James Duchesne (Washington, DC), Jianyuan Hua (New York), Bianca LaCaille, Sarah Cooper (both Seattle), Irina Rudenko (Dallas), and Becca Xu (San Diego). With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 15 consecutive years, according to Mergermarket, and ranked as number one in VC, PE, and M&A in combined global deal volume, according to PitchBook. DLA Piper enables issuers and underwriters to execute complex securities transactions throughout the world. We offer tactical approaches to financings across equity and debt capital markets, alternative public offerings (de-SPACs, reverse mergers, and direct listings), and other transformative corporate transactions. Lawyers in our Corporate Governance practice act as outside corporate and securities counsel to a wide range of reporting companies by guiding clients through securities offerings and nuanced disclosure, governance, and compliance matters under SEC, Nasdaq, and NYSE rules and regulations. Boards of directors turn to us to navigate complex transactions, special investigations, and challenging risk oversight matters. Please visit Capital Markets and Public Company Advisory and Market Edge. Related professionals:Stephen AlicantiSidney BurkeCarina MelecaNicholas YoungLuke PostmaWilliam BartowJae KimPaolo MoranteJulia KovacsAurélie ErcoliVictoria RichterSarah TaumanArlette GrabczynskaMichael MadiganPriya NarahariJames DuchesneJianyuan HuaBianca LaCailleSarah CooperIrina RudenkoBecca Xu 1 Dec 2025
M&A Healthcare & Life Sciences DLA PiperBaker McKenzie USD 1.75bn 30 NAMED
DLA Piper advises Cantor Equity Partners III, Inc. in business combination with AIR Limited 1 Dec 2025
M&A DLA Piper USD 1.75bn 22 NAMED
DLA Piper advises underwriters in initial public offering of Strive, Inc’s SATA Stock 1 Dec 2025
Capital Markets & IPO DLA Piper 6 NAMED
DLA Piper advises the initial purchasers in TeraWulf Inc.’s US$1.025 billion convertible notes offering 14 Nov 2025
Capital Markets & IPO Technology DLA Piper USD 1.02bn 7 NAMED
DLA Piper advises the underwriters in Satellogic’s public offering 8 Nov 2025
Capital Markets & IPO DLA Piper USD 90m 3 NAMED
DLA Piper advises Cohu on US$287.5 million convertible senior notes offering 6 Oct 2025
Capital Markets & IPO Technology DLA Piper USD 288m 7 NAMED
Hogan Lovells advises Azerion on the sale of Whow Games to DoubleDown Interactive 16 Jul 2025
M&A Technology Hogan Lovells Cadwalader EUR 55m 1 NAMED
K&L Gates Advises SoniVie in its Acquisition by Boston Scientific for US$600 Million 6 Mar 2025
M&A Healthcare & Life Sciences K&L Gates USD 600m 13 NAMED
Latham & Watkins Advises Callio Therapeutics on US$187 Million Series A Financing and Concurrent Exclusive License From Hummingbird Bioscience 5 Mar 2025
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLPLatham & Watkins LLP USD 187m 12 NAMED
DLA Piper advises Underwriters in Butterfly Network’s US$86.9 million Public Offering 12 Feb 2025
Capital Markets & IPO Healthcare & Life Sciences DLA Piper USD 86.9m 9 NAMED
DLA Piper advises Bacardi in US$1 billion notes offering 4 Feb 2025
Capital Markets & IPO Consumer & Retail DLA Piper USD 1bn 5 NAMED
DLA Piper Advises the Underwriters, Led by Roth Capital Partners, LLC, on Lakeland Industries, Inc.’s Underwritten Public Offering of 2,093,000 Shares of Common Stock 4 Feb 2025
Capital Markets & IPO DLA Piper 3 NAMED
DLA Piper advises initial purchasers, led by Cantor Fitzgerald & Co., in US$650 million convertible notes offering for CleanSpark, Inc. 19 Dec 2024
Capital Markets & IPO Technology DLA Piper USD 650m 7 NAMED
K&L Gates Advises Auto Components Manufacturer Motherson on Acquisition of Japanese Manufacturer Atsumitec 17 Dec 2024
M&A Industrials & Manufacturing K&L Gates 19 NAMED
DLA Piper advises TD Cowen as underwriter in MdxHealth’s US$40 million public offering of ordinary shares 11 Oct 2024
Capital Markets & IPO Healthcare & Life Sciences DLA Piper USD 40m 3 NAMED
DLA Piper advises Jones in Elicio Therapeutics’ US$40 million ATM and US$11.5 million public offering 16 Jul 2024
Capital Markets & IPO Healthcare & Life Sciences DLA Piper USD 40m 5 NAMED
Latham Advises on Financing for Frazier Healthcare Partners’ Completed Acquisition of BioMatrix 3 Jul 2024
Private Equity & Buyouts Healthcare & Life Sciences Latham & Watkins LLP 11 NAMED
Hogan Lovells advises Seattle Sounders FC in investment in NWSL’s Seattle Reign FC 3 Jul 2024
Venture Capital & Growth Hospitality & Leisure Hogan Lovells Cadwalader 6 NAMED
Latham & Watkins Advises Carlyle on Investment in Seattle Reign FC 18 Jun 2024
Venture Capital & Growth Hospitality & Leisure Latham & Watkins LLP 24 NAMED
DLA Piper’s advises FinTech Collective on USD8 million investment in WheeKeep 14 Jun 2024
Venture Capital & Growth Technology DLA PiperAlShahrani Law Firm USD 8m 7 NAMED
Sidley Represents Impel Pharmaceuticals in Its Chapter 11 Filing 27 Dec 2023
Restructuring & Insolvency Healthcare & Life Sciences Sidley 8 NAMED
DLA Piper advises Northrim Horizon in closing US$153 Million Fund II 20 Apr 2023
Fund Formation Financial Services DLA Piper USD 153m 6 NAMED
DLA Piper advises FinLab EOS VC on investment in Spark Change 16 Nov 2020
Venture Capital & Growth Technology DLA Piper USD 4.50m 4 NAMED
DLA Piper advises on China’s Newater Technology privatization 1 Oct 2020
M&A DLA Piper USD 3.65 9 NAMED
DLA Piper advises Edifecs in growth investment from TA Associates and Francisco Partners 24 Sept 2020
Private Equity & Buyouts Healthcare & Life Sciences DLA Piper 12 NAMED